ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,607,000 | -5.5% | 65,900 | 0.0% | 0.02% | -11.1% |
Q1 2021 | $1,700,000 | -29.2% | 65,900 | +46.8% | 0.02% | -33.3% |
Q4 2020 | $2,400,000 | +29.6% | 44,900 | 0.0% | 0.03% | +3.8% |
Q3 2020 | $1,852,000 | -14.9% | 44,900 | 0.0% | 0.03% | -16.1% |
Q2 2020 | $2,176,000 | +22.6% | 44,900 | +6.9% | 0.03% | -8.8% |
Q1 2020 | $1,775,000 | +3.7% | 42,000 | +5.0% | 0.03% | +25.9% |
Q4 2019 | $1,711,000 | -47.4% | 40,000 | -55.8% | 0.03% | -55.7% |
Q3 2019 | $3,253,000 | +17.2% | 90,400 | -12.9% | 0.06% | +29.8% |
Q2 2019 | $2,775,000 | -0.4% | 103,800 | 0.0% | 0.05% | -69.3% |
Q1 2019 | $2,787,000 | +79.9% | 103,800 | +8.4% | 0.15% | +50.0% |
Q4 2018 | $1,549,000 | +30.9% | 95,800 | +68.1% | 0.10% | +36.0% |
Q3 2018 | $1,183,000 | +52.4% | 57,000 | +65.0% | 0.08% | -2.6% |
Q1 2018 | $776,000 | -26.4% | 34,550 | -1.4% | 0.08% | -30.0% |
Q4 2017 | $1,055,000 | -76.1% | 35,050 | -70.0% | 0.11% | -76.1% |
Q3 2017 | $4,407,000 | -24.7% | 117,000 | -37.1% | 0.46% | -33.4% |
Q2 2017 | $5,854,000 | +278.4% | 186,000 | +313.3% | 0.69% | +235.9% |
Q1 2017 | $1,547,000 | +19.2% | 45,000 | 0.0% | 0.21% | -22.6% |
Q4 2016 | $1,298,000 | -9.3% | 45,000 | 0.0% | 0.27% | +2.7% |
Q3 2016 | $1,431,000 | -2.1% | 45,000 | 0.0% | 0.26% | -5.8% |
Q2 2016 | $1,461,000 | +16.1% | 45,000 | 0.0% | 0.28% | +20.6% |
Q1 2016 | $1,258,000 | – | 45,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |